Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RZLT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
28 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
144 filers reported a long position in RZLT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FEDERATED HERMES, INC. | $67.6M | 13M | Unchanged |
| RA CAPITAL MANAGEMENT, L.P. | $49.1M | 9.4M | +2.9% |
| BlackRock, Inc. | $40.1M | 7.7M | +22.3% |
| Opaleye Management Inc. | $32.8M | 6.3M | Unchanged |
| BALYASNY ASSET MANAGEMENT L.P. | $24.2M | 4.7M | -7.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.9M | 3.8M | +8.9% |
| Siren, L.L.C. | $17.3M | 3.3M | Unchanged |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $13.3M | 2.6M | +1,062.2% |
| JENNISON ASSOCIATES LLC | $12.8M | 2.5M | -28.5% |
| GEODE CAPITAL MANAGEMENT, LLC | $11.3M | 2.2M | +10.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.